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Apoptolidins A-D are microbial secondary metabolites shown to be selectively cytotoxic against several
cancer cell lines and noncytotoxic against normal cells. Total syntheses of apoptolidinones A and D are
reported. The efﬁcient synthetic strategy leading to the apoptolidinones features construction of the common
20-membered macrolactone by an intramolecular Suzuki reaction and stereocontrolled aldol reactions
establishing the C19/C20 and C22/C23 stereocenters. In contrast to apoptolidin A, the aglycones
apoptolidinone A and D were shown to be noncytotoxic when evaluated against human lung cancer cells
(H292).
Introduction
Small molecule natural products provide opportunities for
scientiﬁc advances in chemistry and biology through their study.
An excellent example of this line of investigation is the
discovery and study of cell-speciﬁc apoptosis-inducing natural
products. In the 1990s Seto and Hayakawa initiated a cell-based
screening program aimed at the identiﬁcation of new genotype-
selective cytotoxic agents from microbial extracts.
1 In 1993 the
Seto group reported the isolation of apoptolidin, a 20-membered
macrolide found to induce apoptosis in rat glia cells transformed
with the adenovirus oncogene and produced by Nocardiopsis
sp. (ca. 200 mg/2 L of fermentation).
2 Subsequently several
minor apoptolidin congeners were isolated from the same
microorganism by Wender’s group and given the names
apoptolidin B-D with apoptolidin adopting the name apopto-
lidin A (Figure 1).
3 Apoptolidins A-D were reported to inhibit
growth of H292 cancer cells (lung carcinoma) in the submi-
cromolar range, with apoptolidin B showing the greatest activity
(GI50 ) 7 ( 4 nM).
Not surprisingly, the reported cell-selective induction of
apoptosis by apoptolidin A stimulated investigations on several
research fronts in order to better understand the reported cell-
selective cytotoxicity. Khosla and co-workers determined that
apoptolidin A and structurally related cytotoxic macrolides
ossamycin and cytovaricin inhibit mitochondrial F0F1-ATPase,
identifying this enzyme as a promising target for the develop-
ment of cell-selective anticancer agents.
4 The apoptolidins have
proven to be rather labile compounds easily subjected to a base-
induced acyl migration from the C19 to C20 hydroxyl group to
produce isoapoptolidins (Figure 1),
5 compounds possessing
diminished activity against mitochondrial F0F1-ATPase. The
molecular complexity and instability of apoptolidin A has led
(1) (a) Hayakawa, Y.; Adachi, K.; Komeshima, N. J. Antibiot. 1987, 40,
1349–1352. (b) Hayakawa, Y.; Sohda, K.; Shinya, K.; Hidaka, T.; Seto, H. J.
Antibiot. 1995, 48, 954–961. (c) Hayakawa, Y.; Sohda, K. Y.; Furihata, K.;
Kuzuyama, T.; ShinYa, K.; Seto, H. J. Antibiot. 1996, 49, 974–979. (d)
Hayakawa, Y.; Sohda, K. Y.; Seto, H. J. Antibiot. 1996, 49, 980–984.
(2) (a) Kim, J. W.; Adachi, H.; ShinYa, K.; Hayakawa, Y.; Seto, H. J.
Antibiot. 1997, 50, 628–630. (b) Hayakawa, Y.; Kim, J. W.; Adachi, H.; Shin-
ya, K.; Fujita, K.; Seto, H. J. Am. Chem. Soc. 1998, 120, 3524–3525.
(3) (a) Wender, P. A.; Longcore, K. E. Org. Lett. 2007, 9, 691–694. (b)
Wender, P. A.; Sukopp, M.; Longcore, K. Org. Lett. 2005, 7, 3025–3028.
(4) (a) Salomon, A. R.; Voehringer, D. W.; Herzenberg, L. A.; Khosla, C.
Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 14766–14771. (b) Salomon, A. R.;
Voehringer, D. W.; Herzenberg, L. A.; Khosla, C. Chem. Biol. 2001, 8, 71–80.
(5) (a) Pennington, J. D.; Williams, H. J.; Salomon, A. R.; Sulikowski, G. A.
Org. Lett. 2002, 4, 3823–3825. (b) Wender, P. A.; Gulledge, A. V.; Jankowski,
O. D.; Seto, H. Org. Lett. 2002, 4, 3819–3822.
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possessing superior stability and/or pharmacokinetic properties.
6
Comparison of the enzyme inhibition of mitochondrial F0F1-
ATPase to antiproliferative activity in E1A-transformed rat
ﬁbroblasts of apoptolidin A derived analogs suggested either
the existence of a secondary biological target or a more complex
mode of action.
The complex molecular architecture and novel cytotoxic
proﬁle of apoptolidin A has stimulated considerable interest from
the synthetic community.
7 Total syntheses of the fully glyco-
sylated ensemble, apoptolidin A, have been reported by the
groups of Nicolaou and Koert.
8 Several groups including our
own have described the synthesis of apoptolidinone (A).
9 We
describe herein the total synthesis of apoptolidinones A and D
and evaluation of their antiproliferative properties.
Results and Discussion
An unsaturated 20-membered macrolactone conjugated to a
stereochemically rich pyran ring constitutes the gross structural
features of apoptolidinone A/D, reminiscent of polyketides such
as the baﬁlomycin macrolides.
10 We anticipated macrolide I
(Scheme 1) would serve as a logical synthetic precursor to
apoptolidinone. However, because of the tendency of apoptolidin
to ring expand to iso-apoptolidin under basic conditions, proper
choice of protecting groups was considered of paramount
importance. As we gathered information from published studies
and work from our own group, we ultimately identiﬁed
triethylsily (P ) TES) groups as the protecting groups of choice.
Disconnection of the macrolide at C5-C6 which relied on
introduction of a vinyl boronate by a cross-metathesis reaction
allowed, in principle, synthetic access to apoptolidinones A (R
) Me) and D (R ) H). Disconnection at C11-C12 and
application of two stereoselective aldol retrons leads to the
identiﬁcation of fragments II-VI as key building blocks for
the assembly of apoptolidinone A/D.
The C23-C28 fragment (Scheme 1, IV) was derived by a
Crimmins syn aldol reaction between the chlorotitanium enolate
derived from oxazolidinethione 9 and aldehyde 4 (Scheme 2).
11
The latter was easily prepared from (R)-glycidyl methyl ether
(1) starting with epoxide ring opening with the carbanion derived
from 1,3-dithiane followed by alcohol protection and dithiane
hydrolysis. Reduction of the TES protected aldol 6 with lithium
borohydride led to alcohol 7, which on oxidation under Swern
conditions gave aldehyde 8.
Our synthetic strategy (Scheme 1) projected the equivalent
of a C20-C22 fragment (VI) to conjoin aldehydes IV and V
through two regio- and stereoselective aldol reactions by one
of two coupling orders (VI + IV + V and VI + V + IV). To
this end we developed reaction conditions that would allow
access to either isomeric silyl enol ethers 12 or 13 starting from
TES protected 1-hydroxy-2-butanone 11 (Scheme 3).
12 Depro-
tonation of 11 under kinetic conditions (LDA, THF, -78 °C)
followed by the addition of TMSCl afforded a 15:73:12 mixture
of isomers (Z)-12,( E)-12, and (Z)-13 (Scheme 3).
13,14 Ther-
modynamic conditions (TMSOTf, Et3N, THF, 0 °C) afforded
(Z)-13 as the exclusive isomer as determined by GC analysis.
(6) (a) Wender, P. A.; Jankowski, O. D.; Longcore, K.; Tabet, E. A.; Seto,
H.; Tomikawa, T. Org. Lett. 2006, 8, 589–592. (b) Wender, P. A.; Jankowski,
O. D.; Tabet, E. A.; Seto, H. Org. Lett. 2003, 5, 2299–2302. (c) Wender, P. A.;
Jankowski, O. D.; Tabet, E. A.; Seto, H. Org. Lett. 2003, 5, 487–490.
(7) (a) Abe, K.; Kato, K.; Arai, T.; Rahim, M. A.; Sultana, I.; Matsumura,
S.; Toshima, K. Tetrahedron Lett. 2004, 45, 8849–8853. (b) Bouchez, L. C.;
Vogel, P. Chem. Eur. J. 2005, 11, 4609–4620. (c) Chng, S. S.; Xu, J.; Loh,
T. P. Tetrahedron Lett. 2003, 44, 4997–5000. (d) Craita, C.; Didier, C.; Vogel,
P. J. Chem. Soc., Chem. Commun. 2007, 2411–2413. (e) Crimmins, M. T.; Long,
A. Org. Lett. 2005, 7, 4157–4160. (f) Daniel, P. T.; Koert, U.; Schuppan, J.
Angew. Chem., Int. Ed. 2006, 45, 872–893. (g) Jin, B. H.; Liu, Q. S.; Sulikowski,
G. A. Tetrahedron 2005, 61, 401–408. (h) Nicolaou, K. C.; Li, Y. W.;
Weyershausen, B.; Wei, H. X. J. Chem. Soc., Chem. Commun. 2000, 307–308.
(i) Paquette, W. D.; Taylor, R. E. Org. Lett. 2004, 6, 103–106. (j) Schuppan, J.;
Ziemer, B.; Koert, U. Tetrahedron Lett. 2000, 41, 621–624. (k) Sulikowski, G. A.;
Lee, W. M.; Jin, B.; Wu, B. Org. Lett. 2000, 2, 1439–1442. (l) Toshima, K.;
Arita, T.; Kato, K.; Tanaka, D.; Matsumura, S. Tetrahedron Lett. 2001, 42, 8873–
8876. (m) Handa, M.; Scheidt, K. A.; Bossart, M.; Zheng, N.; Roush, W. R. J.
Org. Chem. 2008, 73, 1031–1035. (n) Handa, M.; Smith, I. I. I.; W, J.; Roush,
W. R. J. Org. Chem. 2008, 73, 1036–1039.
(8) (a) Nicolaou, K. C.; Fylaktakidou, K. C.; Monenschein, H.; Li, Y. W.;
Weyershausen, B.; Mitchell, H. J.; Wei, H. X.; Guntupalli, P.; Hepworth, D.;
Sugita, K. J. Am. Chem. Soc. 2003, 125, 15433–15442. (b) Nicolaou, K. C.; Li,
Y.; Fylaktakidou, K. C.; Mitchell, H. J.; Wei, H. X.; Weyershausen, B. Angew.
Chem., Int. Ed. 2001, 40, 3849–3854. (c) Nicolaou, K. C.; Li, Y. W.;
Fylaktakidou, K. C.; Mitchell, H. J.; Sugita, K. Angew. Chem., Int. Ed. 2001,
40, 3854–3857. (d) Nicolaou, K. C.; Li, Y. W.; Sugita, K.; Monenschein, H.;
Guntupalli, P.; Mitchell, H. J.; Fylaktakidou, K. C.; Vourloumis, D.; Gianna-
kakou, P.; O’Brate, A. J. Am. Chem. Soc. 2003, 125, 15443–15454. (e) Wehlan,
H.; Dauber, M.; Fernaud, M. T. M.; Schuppan, J.; Keiper, S.; Mahrwald, R.;
Garcia, M. E. J.; Koert, U. Chem. Eur. J. 2006, 12, 7378–7397. (f) Wehlan, H.;
Dauber, M.; Fernaud, M. T. M.; Schuppan, J.; Mahrwald, R.; Ziemer, B.; Garcia,
M. E. J.; Koert, U. Angew. Chem., Int. Ed. 2004, 43, 4597–4601.
(9) (a) Crimmins, M. T.; Christie, H. S.; Chaudhary, K.; Long, A. J. Am.
Chem. Soc. 2005, 127, 13810–13812. (b) Schuppan, J.; Wehlan, H.; Keiper, S.;
Koert, U. Angew. Chem., Int. Ed. 2001, 40, 2063–2066. (c) Schuppan, J.; Wehlan,
H.; Keiper, S.; Koert, U. Chem. Eur. J. 2006, 12, 7364–7377. (d) Wu, B.; Liu,
Q. S.; Sulikowski, G. A. Angew. Chem., Int. Ed. 2004, 43, 6673–6675.
(10) Isolation: (a) Hatﬁeld, G. M.; Woodard, R. W.; Son, J. K. J. Nat. Prod
1992, 55, 753–759. (b) Meyer, M.; Kellerschierlein, W.; Drautz, H.; Blank, W.;
Zahner, H. HelV. Chim. Acta 1985, 68, 83–94. Total synthesis: (c) Scheidt, K. A.;
Bannister, T. D.; Tasaka, A.; Wendt, M. D.; Savall, B. M.; Fegley, G. J.; Roush,
W. R. J. Am. Chem. Soc. 2002, 124, 6981–6990.
(11) (a) Crimmins, M. T.; King, B. W.; Tabet, E. A.; Chaudhary, K. J. Org.
Chem. 2001, 66, 894–902. (b) Crimmins, M. T.; King, B. W.; Tabet, E. A. J. Am.
Chem. Soc. 1997, 119, 7883–7884.
(12) Cho, B. T.; Chun, Y. S. J. Org. Chem. 1998, 63, 5280–5282.
(13) Paquette, L. A.; O’Neil, S. V.; Guillo, N.; Zeng, Q. B.; Young, D. G.
Synlett 1999, 1857–1866.
FIGURE 1. Structures of apoptolidins and isoapoptolidins.
Ghidu et al.
4950 J. Org. Chem. Vol. 73, No. 13, 2008The C6-C11 fragment that incorporates two stereocenters
(C8 and C9) was to be introduced in the form a vinyl boronate
(II, Scheme 1). To this end, we examined the asymmetric
crotylation of 3-iodoacrolein (14)
15 and 3-borylacrolein (15)
16
employing either Roush’s (18)
17 or Brown’s (19) syn selective
crotylating agent (Scheme 4).
18 As reported earlier, addition of
the (Z)-crotylboronate reagent 18 to the pinacol ester of
3-boronoacrolein afforded, following in situ silylation, syn
homoallylic ether 17 with modest enantioselectivity (80% ee)
and yield (40-43%).
7g The addition of 18 to 3-iodoacrolein
proceeded with poor asymmetric induction (26% ee), whereas
addition of the Brown reagent (19)t o14 gave 16 in high
enantiomeric excess (90% ee) and good yield (67%). Vinyl
iodide 16 was readily converted to vinyl boronate 17 by
lithium-halogen exchange followed by a boronate quench.
Construction of the C12-C19 fragment (V, Scheme 1) started
from lactone 20, readily derived from (S)-malic acid
19 and
converted to 3-methoxy-γ-butyrolactone (21) (Scheme 5).
20
Reduction of lactone 21 with DIBAL-H afforded lactol 22,
(14) The ratio of isomers 12 and 13 was determined by GC analysis. The
double bond geometry of silylenol ethers 12 and 13 was assigned by analysis of
the corresponding NOESY spectra.
(15) Meyer, C.; Marek, I.; Normant, J. F. Synlett 1993, 386–388.
(16) Jehanno, E.; Vaultier, M. Tetrahedron Lett. 1995, 36, 4439–4442.
(17) (a) Roush, W. R.; Halterman, R. L. J. Am. Chem. Soc. 1986, 108, 294–
296. (b) Roush, W. R.; Ando, K.; Powers, D. B.; Palkowitz, A. D.; Halterman,
R. L. J. Am. Chem. Soc. 1990, 112, 6339–6348.
(18) Brown, H. C.; Bhat, K. S. J. Am. Chem. Soc. 1986, 108, 5919–5923.
(19) Saito, S.; Hasegawa, T.; Inaba, M.; Nishida, R.; Fujii, T.; Nomizu, S.;
Moriwake, T. Chem. Lett. 1984, 1389–1392.
(20) Masse, C. E.; Yang, M.; Solomon, J.; Panek, J. S. J. Am. Chem. Soc.
1998, 120, 4123–4134.
SCHEME 1
SCHEME 2. Synthesis of Fragment 8
a
a Reagents and conditions: (a) n-BuLi, 1,3-dithiane, THF, -40 °C, 95%;
(b) TBSCl, ImH, DMAP, DMF, 0 °C, 95%; (c) MeI (xs), K2CO3, MeCN/
water (10:1), 40 °C, 90%; (d) 9, TiCl4,0°C then (-)-sparteine, -78 to 0
°C, CH2Cl2, 95%; (e) TESCl, ImH, DMF, 0 °C, 95%; (f) LiBH4, MeOH,
0 °C, 90%; (g) (COCl)2, DMSO, Et3N, -78 °C, 88%.
SCHEME 3. Synthesis of Silyl Enol Ethers 12 and 13
a
a Reagents and conditions: (a) TESCl, ImH, CH2Cl2,0°C, 77%; (b)
LDA, THF, -78 °C then TMSCl, 80%; (c) TMSOTf, Et3N, THF, 0 °C,
92%.
SCHEME 4
SCHEME 5. Synthesis of Fragment 29
a
a Reagents and conditions: (a) Ag2O, MeI (solvent) 86%; (b) DIBAL-
H, THF, -78 °C; (c) 1,3-propanedithiol, BF3·OEt2,C H 2Cl2,2 8°C, 86%
from lactone 21; (d) (COCl)2, DMSO, i-Pr2NEt, -78 °C, 98%; (e) 25, Mg,
1,2-dibromoethane, Et2O, -78 °C, 85%; (f) TESCl, ImH, CH2Cl2,2 8°C;
(g) I2,C H 2Cl2,0°C, 90% from 26; (h) MeI (xs), K2CO3, MeCN/pH 7
buffer (4:1), 28 °C, 92%.
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J. Org. Chem. Vol. 73, No. 13, 2008 4951which on condensation with 1,3-propanedithiol afforded dithiane
23. Swern oxidation of primary alcohol 23 provided aldehyde
24 in near quantitative yield. A ﬁve-carbon unit was introduced
to aldehyde 24 by chelation-controlled addition of the Grignard
reagent derived from bromide 25, prepared from dihydrofuran
according to Kocienski’s procedure as described by Koert and
co-workers in their reported synthesis of apoptolidinone.
9b,21
A dichloromethane solution of secondary alcohol 26 was treated
sequentially with iodine followed by imidazole and triethyl-
chlorosilane in one pot to provide vinyl iodide 28 in 89-96%
yield. Dithiane hydrolysis of 28 was efﬁciently accomplished
using the Fetizon-Jurion procedure to provide aldehyde 29 in
64-74% yield.
22 With fragments II-VI available, we turned
our attention to their coupling to complete the synthesis of
apoptolidinone A (Scheme 6).
Initially, Suzuki-Miyaura cross-coupling of aldehyde 29 and
vinyl boronate 17 was accompanied by elimination of the
 -methoxy group of aldehyde 30 to afford the corresponding
R, -unsaturated aldehyde.
23 However optimization of coupling
conditions [Tl(OEt), Pd(PPh3)4, THF(aq)] and reaction time (15
min) eventually led to an observed 70% yield of 30 without
any observed   elimination.
24 We next turned our attention to
investigating two key stereocontrolled aldol reactions; leading
to the formation of the C(19)-C(20) and C(22)-C(23)
carbon-carbon bonds. Mukaiyama aldol reaction between
aldehyde 30 and an 8:1 mixture of silyl enol ether 12 and 13
afforded anti,syn-31a as the major isomer (31a-d: 12:3.8:1.6:
1) (Figure 2).
25 The assigned C(19)-C(20) syn relative stere-
ochemistry rested on the observed coupling constant of the aldol
product (J19,20 ) 3.5 Hz) and the proclivity for the formation
of syn aldol products in the Mukaiyama aldol reaction of silyl
enol ethers (regardless of double bond geometry) with chiral
aldehydes.
26 The assigned C(17)-C(19) anti conﬁguration rested
on the well-established 1,3-asymmetric induction model pro-
posed by Evans and co-workers in the mid-1990s.
27 The second
major isomer was assigned the syn,syn (31b) relative stereo-
chemistry (J19,20 ) 3.9 Hz) (Figure 2). The minor aldol products
were assigned the structures of anti,anti-31c and syn,anti-31d
(J19,20 ) 4.7 and 4.2 Hz), although the assignment of the
C(17)-C(19) relative conﬁguration remained ambiguous. The
carbonyl resonances in the 13C NMR of 31c and 31d were not
observed due to the trace amount of material isolated. Yamagu- (21) (a) Fargeas, V.; LeMenez, P.; Berque, I.; Ardisson, J.; Pancrazi, A.
Tetrahedron 1996, 52, 6613–6634. (b) Kocienski, P.; Wadman, S.; Cooper, K.
J. Am. Chem. Soc. 1989, 111, 2363–2365.
(22) Fetizon, M.; Jurion, M. J. Chem. Soc., Chem. Commun. 1972, 382–
384.
(23) Miyaura, N.; Yamada, K.; Suginome, H.; Suzuki, A. J. Am. Chem. Soc.
1985, 107, 972–980.
(24) Frank, S. A.; Chen, H.; Kunz, R. K.; Schnaderbeck, M. J.; Roush, W. R.
Org. Lett. 2000, 2, 2691–2694.
(25) No aldol products derived from silyl enol ether 13 were observed.
(26) Evans, D. A.; Yang, M. G.; Dart, M. J.; Duffy, J. L.; Kim, A. S. J. Am.
Chem. Soc. 1995, 117, 9598–9599.
(27) (a) Evans, D. A.; Dart, M. J.; Duffy, J. L.; Yang, M. G. J. Am. Chem.
Soc. 1996, 118, 4322–4343. (b) Evans, D. A.; Duffy, J. L.; Dart, M. J.
Tetrahedron Lett. 1994, 35, 8537–8540.
SCHEME 6. Synthesis of Apoptolidinone A
a
a Reagents and conditions: (a) 17, Pd(Ph3P)4, Tl(OEt), THF/H2O (3:1), 28 °C, 86%; (b) 12,B F 3·OEt2, CaH2,C H 2Cl2, -94 °C, 72%; (c) 2,4,6-trichlorobenzoyl
chloride, Et3N, DMAP, PhMe, -78 °C, 71%; (d) LHMDS, THF, HMPA, -78 °C, 2 h then 8, THF, 48%; (e) TESOTf, 2,6-lutidine, CH2Cl2,0°C, 97%; (f)
34, isopropenyl pinacol boronic ester (5 equiv), PhMe, 50 °C, 46 h, 22%; (g) Pd(Ph3P)4, Tl(OEt), THF/H2O (3:1), 28 °C, 30 min, 84%; (h) HF·pyridine,
THF, -10 to 10 °C, 48h, 94%.
FIGURE 2. Aldol stereoisomers derived from Mukaiyama aldol
between aldehyde 30 and silylenol ether 12.
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4952 J. Org. Chem. Vol. 73, No. 13, 2008chi esteriﬁcation of anti,syn-31 with carboxylic acid 32
28 led
to isolation of dienoate 33 in 83% yield.
29 We anticipated the
matched double stereodifferentiating aldol reaction between a
metal enolate derived from ketone 33 and aldehyde 8 to proceed
with high stereoselectivity.
30 In the event kinetic deprotonation
(LHMDS, HMPA, THF, -78 °C) of 33 followed by aldol
condensation with aldehyde 8 afforded syn aldol product 35 as
a single isomer in 48% yield. Following silylation of 35 a
dichloromethane solution of alkene 36, isopropenyl boronate,
and Grubbs second-generation catalyst (34) held at reﬂux for
5 h afforded a 30% yield of vinylboronate 37 that was judged
by 1H NMR spectroscopy analysis to be a single geometric
isomer. However, analysis by HPLC revealed a signiﬁcant
quantity of an isomeric byproduct as determined by further 1H
NMR analysis.
31 Employing the same catalyst in toluene heated
to 50 °C resulted in a 22% yield of 37 and signiﬁcant reduction
of the isomeric byproduct.
32 Vinylboronate 37 derived by the
latter procedure subjected to an intramolecular Suzuki-Miyaura
reaction delivered macrolactone 38 in a consistent 84% yield.
Finally, desilylation of 38 provided apoptolidinone A in 94%
yield.
A synthesis of apoptolidinone D required only a change in
the cross-metathesis partner of alkene 36 from isopropenyl
boronic ester to 1-propenyl boronic ester. However, we decided
to probe the assembly of alkene 36 by an alternate order of
aldol coupling (cf. Scheme 1, VI + V + IV). To this end, we
examined the addition of silyl enol ether (Z)-13 to syn
substituted aldehyde 8 (Scheme 7). As pointed out by Evans,
syn substituted aldols are stereochemically nonreinforcing
substrates where the C24 substitutent of 8 favors a Felkin while
the C25 a non-Felkin addition.
26,33 Literature precedent sug-
gested the stereoselectivity of the addition of (Z)-13 to 8 could
not be predicted with conﬁdence. In the event, we were surprised
to observe treatment of a solution of 8 and (Z)-13 with
borontriﬂuoride etherate led not to a Mukaiyama aldol reaction
but instead silyl enol ether 39 as a single stereoisomer, the
product of a heteroene reaction.
34 Stereochemical assignment
of C22 and C23 was based on NMR analysis of pyran 40,
derived from 39 by exhaustive desilylation (p-TSA, MeOH, 28
°C, 69%). The NOESY spectrum of 40 revealed NOEs from
H-23 to 22-Me and 24-Me and H-23 to H-27.
35 This observation
combined with the large coupling constants (J22-23 ) 9.9 Hz
and J23-24 ) 9.9 Hz) led to the assigned relative stereochemistry
shown, indicating a Felkin addition to 8, the undesired stereo-
selectivity.
Apoptolidinone D was completed starting with a cross-
metathesis between 36 and 1-propenyl pinacol boronic ester
promoted by Grubbs second generation catalyst to deliver vinyl
boronate 41 in superior yield and stereoselectivity relative to
the same reaction with isopropenyl boronate leading to apop-
tolidinone A. Macrocyclization of 41 under the previously
described Suzuki conditions gave 42 in 95% yield. Desilylation
of 42 provided apoptolidinone D in 87% yield.
Wender’s group has reported GI50’s for apoptolidin A (32
nM), apoptolidin B (7 nM), apoptolidin C (24 nM), and
apoptolidin D (110 nM) against H292 (human lung carcinoma)
cells.
3,36 The effect reported by Wender’s group was cytostasis
observed over a 2-3 day (ca. 72 h) period. We observed that
treatment of H292 lung carcinoma cells with apoptolidin A
results in growth arrest. In addition, however, extended main-
tenance of cells in the presence of apoptolidin A results in a
delayed toxicity not previously reported. The effect is drastic,
resulting in >95% cell death after 7 days in culture with
apoptolidin A concentrations as low as 30 nM (Figure 3). In
contrast, the synthetic aglycones apoptolidonone A and apop-
(28) For the preparation of carboxylic acid 32, see ref 7g.
(29) Inanaga, J.; Hirata, K.; Saeki, H.; Katsuki, T.; Yamaguchi, M. Bull.
Chem. Soc. Jpn. 1979, 52, 1989–1993.
(30) (a) Evans, D. A.; Dart, M. J.; Duffy, J. L.; Rieger, D. L. J. Am. Chem.
Soc. 1995, 117, 9073–9074. (b) Evans, D. A.; Yang, M. G.; Dart, M. J.; Duffy,
J. L. Tetrahedron Lett. 1996, 37, 1957–1960.
(31) The minor geometric isomer could not be completely separated from
other by-products and was not fully characterized. .
(32) (a) Chatterjee, A. K.; Choi, T. L.; Sanders, D. P.; Grubbs, R. H. J. Am.
Chem. Soc. 2003, 125, 11360–11370. (b) Chatterjee, A. K.; Grubbs, R. H. Angew.
Chem., Int. Ed. 2002, 41, 3171–3173.
(33) Evans, D. A.; Dart, M. J.; Dugy, J. L.; Yang, M. G.; Livingston, A. B. J.
Am. Chem. Soc. 1995, 117, 6619–6620.
(34) Ruck, R. T.; Jacobsen, E. N. Angew. Chem., Int. Ed. 2003, 42, 4771–
4774.
(35) A NOE between H-22 and H-24 is not observed because of overlapping
signals in the NMR spectrum.
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FIGURE 3. Toxicity of apoptolidin A and aglycones in H292 human
lung carcinoma cells. (a) Cells were plated at a density of 500/well in
96-well plates and treated for 7 days with apoptolidin A, apoptolidinone
A, and apoptolidinone D at concentrations from 3 nM to 10 µM.
Viability was measured by loading cells with 2 µM Calcein-AM and
reading plates using a Spectramax (Molecular Dynamics) plate reader;
λabs ) 494, λem ) 517. (b) Effective concentration 50 (EC50) values
for apoptolidin A, apoptolidinone A, and apoptolidinone D. (c) Bright
ﬁeld photomicrographs of H292 cells cultured for 7 days in the presence
of either 10 or 30 nM apoptolidin A.
Apoptolidinones A and D
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growth nor viability at the concentrations tested.
Conclusions
In conclusion, we have developed a convergent synthesis of
apoptolidinones A and D. Evaluation of the cytotoxicity of these
aglycones using human lung cancer cells (H292) conﬁrms the
importance of the sugars of apoptolidin in expressing overall
cytotoxicity as reported by Koert and co-workers.
8e Current
efforts are aimed at the development of synthetic probes aimed
at interrogating the cellular target(s) of the apoptolidins.
Experimental Section
Aldol 31. To a solution of diene 30 (0.40 g, 0.76 mmol) and
silyl enol ethers (7:1, 12/13; 0.83 g, 3.03 mmol, 4 equiv) in
dichloromethane (32 mL) at 0 °C was added CaH2 (64 mg, 1.52
mmol, 2 equiv). After 15 min, the reaction was cooled to -94 °C
and BF3·OEt2 (105 µL, 1.52 mmol, 2 equiv) was added. The
reaction mixture was stirred for 45 min at -94 °C and quenched
with saturated NaHCO3 (25 mL), and the aqueous layer was
extracted with dichloromethane (3 × 50 mL). The combined organic
layers were dried (MgSO4), ﬁltered, and concentrated in Vacuo.
The residue was puriﬁed by ﬂash chromatography (hexanes/EtOAc,
20:1-15:1) to afford 0.39 g (72%) of alcohol 31a-d as a 12:3.8:
1.6:1 mixture of diastereoisomers (by HPLC, 21.4 mm × 25 cm
column, 49 min gradient, 0-10% ethyl acetate in hexanes). For
synthetic purposes the mixture can be advanced to the next step
without further puriﬁcation, as the resulting mixture of Yamaguchi
esteriﬁcation products can be easily separated to afford the desired
ester 33.
Data for 31a. tR ) 34.25 min; [R]25
D -9.1° (c 2.1, CHCl3); IR
(neat) 3505, 2953, 2873, 1724, 1462, 1418, 1244, 1091, 1018 cm-1;
1H NMR (500 MHz C6D6) δ 6.25 (d, J ) 16.0 Hz, 1H), 6.05-5.98
(m, 1H), 5.63 (dd, J ) 16.0, 7.5 Hz, 1H), 5.55 (t, J ) 7.0 Hz, 1H),
5.08-5.03 (m, 2H), 4.24-4.18 (m, 1H), 4.07 (t, J ) 7.5 Hz, 1H),
4.04 (d, J ) 4.0 Hz, 1H). 3.99-3.95 (m, 1H), 3.66 (ddd. J ) 10.0,
4.0, 2.0 Hz, 1H), 3.30 (s, 3H), 2.61 (d, J ) 9.0 Hz, 1H), 2.53-2.38
(m, 4H), 2.25-2.16 (m, 1H), 1.95-1.89 (m, 1H), 1.88-1.82 (m,
1H), 1.76 (s, 3H), 1.66-1.60 (m, 1H), 1.60-1.52 (m, 1H), 1.11
(d, J ) 6.5 Hz, 3H), 1.05-0.99 (m, 21H), 0.91 (t, J ) 8.0 Hz,
9H), 0.68-0.62 (m, 12 H), 0.52 (q, J ) 8.0 Hz, 6H); 13C NMR
(125 MHz, C6D6) δ 213.3, 141.3, 135.7, 133.7, 132.5, 128.6, 114.2,
81.7, 80.8, 78.1, 71.6, 70.6, 58.2, 45.2, 33.5, 32.2, 31.7, 25.3, 15.0,
12.6, 7.3, 7.1, 7.1, 6.9, 5.4, 5.4, 5.0; HRMS (MALDI) m/z 749.5078
[(M + Na)+ calcd for C39H78O6Si3Na, 749.5004].
Data for 31b. tR ) 31.75 min; [R]25
D -2.6° (c 0.16, CHCl3);
IR (neat) 3498, 2955, 2877, 1716, 1459, 1414, 1239, 1083, 1006,
966, 845, 677 cm-1; 1H NMR (500 MHz C6D6) δ 6.27 (dd, J )
15.5, 4.5 Hz, 1H), 6.07-5.98 (m, 1H), 5.65 (dd, J ) 15.5, 7 Hz,
1H), 5.56-5.50 (m, 1H), 5.10-5.04 (m, 2H), 4.25-4.19 (m, 1H),
4.17 (d, J ) 4 Hz, 1H), 4.09 (t, J ) 6.2 Hz, 1H), 3.93-3.88 (m,
1H), 3.44-3.39 (m, 1H), 3.30 (d, J ) 4.5 Hz, 1H), 3.09 (s, 3H),
2.73-2-58 (m, 2H), 2.45-2.32 (m, 2H), 2.24-2.14 (m, 1H), 2.04
(d, J ) 15 Hz, 1H), 1.83-1.73 (m, 2H), 1.76 (s, 3H), 1.59-1.52
(m, 1H), 1.15-1.09 (m, 6H), 1.07-0.94 (m, 27H), 0.69-0.56 (m,
18H); 13C NMR (125 MHz, C6D6) δ 211.9, 141.4, 135.7, 133.8,
132.4, 128.8, 114.3, 84.5, 81.9, 78.1, 73.8, 71.6, 57.1, 45.2, 32.9,
31.9, 31.8, 25.2, 15.1, 12.7, 7.4, 7.2, 7.0, 5.5, 5.4, 5.2; HRMS
(MALDI) m/z 749.5020 [(M + Na)+ calcd for C39H78O6Si3Na,
749.5004].
Data for 31c. tR ) 32.80 min; [R]25
D -9.3° (c 0.08, CHCl3); IR
(neat) 3470, 3400, 2955, 2913, 2878, 2361, 2337, 1714, 1459, 1414,
1377, 1238, 1096, 1008, 968, 912, 844, 741, 671, 558, 522 cm-1;
1H NMR (500 MHz C6D6) δ 6.26 (d, J ) 19.5 Hz, 1H), 6.08-5.97
(m, 1H), 5.65 (dd, J ) 19.5, 9.2 Hz, 1H), 5.58-5.52 (m, 1H),
5.10-5.04 (m, 2H), 4.25-4.20 (m, 1H), 4.14 (d, J ) 5.8 Hz, 1H),
4.09 (t, J ) 7.9 Hz, 1H), 4.00-3.95 (m, 1H), 3.60-3.57 (m, 1H),
3.27 (s, 3H), 3.01 (d, J ) 5 Hz, 1H), 2.62-2.47 (m, 2H), 2.45-2.32
(m, 2H), 2.27-2.15 (m, 1H), 2.00-1.92 (m, 1H), 1.77 (s, 3H),
1.65-1.55 (m, 1H), 1.13 (d, J ) 8.6 Hz, 3H), 1.08-1.00 (m, 18H),
0.95 (t, J ) 10.0 Hz, 9H), 0.66 (q, J ) 9.8 Hz, 12H), 0.58 (q, J )
9.9 Hz, 6H);13C NMR (150 MHz, C6D6) δ 141.4, 135.8, 133.8,
132.5, 128.7, 114.2, 84.5, 82.4, 81.9, 78.1, 73.9, 72.4, 71.6, 71.1,
58.0, 57.1, 45.3, 32.9, 32.5, 32.0, 31.9, 25.2, 15.1, 12.7, 7.4, 7.2,
7.0, 6.9, 5.6, 5.5, 5.4, 5.2, 5.1; HRMS (MALDI) m/z 749.5038 [(M
+ Na)+ calcd for C39H78O6Si3Na, 749.5004].
Data for 31d. tR ) 36.80 min; [R]25
D -50.0° (c 0.01, CHCl3);
IR (neat) 2955, 2878, 1713, 1459, 1414, 1379, 1239, 1105, 1007,
968, 912, 845, 741, 583, 553, 525 cm-1; 1H NMR (500 MHz C6D6)
δ 6.30 (d, J ) 19.6 Hz, 1H), 6.08-5.98 (m, 1H), 5.67 (dd, J )
19.5, 9.1 Hz, 1H), 5.56-5.50 (m, 1H), 5.11-5.04 (m, 2H),
4.30-4.17 (m, 1H), 4.11 (t, J ) 7.9 Hz, 1H), 4.07 (d, J ) 5.2 Hz,
1H), 3.94-3.89 (m, 1H), 3.48 (d, J ) 12.6 Hz, 1H), 3.29 (s, 3H),
2.55-2.32 (m, 4H), 2.22-2.12 (m, 1H), 1.91-1.85 (m, 1H), 1.78
(s, 3H), 1.71-1.59 (m, 2H), 1.51-1.42 (m, 1H), 1.13 (d, J ) 8.5
Hz, 3H), 1.10-1.00 (m, 18H), 0.94 (t, J ) 9.9 Hz, 9H), 0.75-0.62
(m, 12H), 0.56 (q, J ) 9.9 Hz, 6H); 13C NMR (150 MHz, C6D6)
δ 141.4, 135.7, 133.8, 132.2, 128.9, 114.3, 82.1, 81.5, 78.1, 72.9,
70.7, 57.9, 45.3, 34.2, 34.0, 32.1, 25.3, 15.1, 12.7, 7.3, 7.2, 7.1,
7.0, 5.6, 5.5, 5.0; HRMS (MALDI) m/z 749.5030 [(M + Na)+ calcd
for C39H78O6Si3Na, 749.5004].
Macrolactone 38. To a solution of vinyl boronate 37 (5 mg,
3.1 µmol) in THF/H2O (4 mL, 3:1, degassed) was added Pd(Ph3P)4
(0.7 mg, 0.62 µmol, 0.2 equiv). The resulting yellow solution was
stirred for 5 min before TlOEt (0.3 µL, 4.6 µmol, 1.5 equiv) was
added. The solution was stirred for 15 min (color turned from yellow
to gray). The reaction was quenched with saturated NaHCO3 (5
mL), and the aqueous layer was extracted with dichloromethane
(3 × 10 mL). The combined organic layers were dried (MgSO4),
ﬁltered, and concentrated in vacuo. The residue was puriﬁed by
ﬂash chromatography (hexanes/EtOAc, 25:1) to afford 3.5 mg
(84%) of lactone 38 as a colorless oil: [R]25
D +17.5° (c 0.32,
SCHEME 8. Synthesis of Apoptolidinone D
a
a Reagents and conditions: (a) 34, 1-propenyl pinacol boronic ester (10 equiv), PhMe, 80 °C, 6 h then 40 °C, 24 h, 53%; (b) Pd(Ph3P)4, Tl(OEt), THF/
H2O (3:1), 28 °C, 15 min, 95%; (c) HF·pyridine, THF, -10 to 10 °C, 48 h, 87%.
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4954 J. Org. Chem. Vol. 73, No. 13, 2008CHCl3); IR (neat) 3497, 3382, 2954, 2915, 2877, 1700, 1459, 1241,
1111, 1081, 968, 835, 781, 741; 1H NMR (500 MHz, C6D6) δ 7.49
(s, 1H), 6.26 (s, 1H), 6.06 (d, J ) 16.0 Hz, 1H), 5.71-5.67 (m,
1H), 5.57 (t, J ) 8.0 Hz, 1H), 5.38 (dd, J ) 16.0, 9.0 Hz, 1H),
5.16 (d, J ) 10.0 Hz, 1H), 5.00 (d, J ) 4.0 Hz, 1H), 4.31-4.28
(m, 1H), 4.24 (dd, J ) 9.5, 1.0 Hz, 1H), 3.94-3.89 (m, 1H), 3.82
(t, J ) 8.5 Hz, 1H), 3.60 (dt, J ) 8.5, 2.5 Hz, 1H), 3.52-3.44 (m,
1H), 2.48 (s, 3H), 3.39-3.36 (m, 2H), 3.16 (s, 3H), 3.02 (t, J )
8.5 Hz, 1H), 2.61-2.56 (m, 1H), 2.53-2.46 (m, 1H), 2.16-1.90
(m, 4H), 2.07 (s, 3H), 1.82 (s, 3H), 1.80-1.74 (m, 1H), 1.63 (d, J
) 1.0 Hz, 3H), 1.59 (s, 3H), 1.41 (d, J ) 7.0 Hz, 3H), 1.36-1.26
(m, 6H), 1.21 (d, J ) 7.0 Hz, 3H), 1.17-1.13 (m, 21H), 1.10 (d,
J ) 7.0 Hz, 3H), 1.08-1.02 (m, 18 H), 1.00 (s, 9H), 0.97-0.80
(m, 18 H), 0.75-0.64 (m, 15 H), 0.18 (s, 3H), 0.16 (s, 3H); 13C
NMR (125 MHz, C6D6) δ 209.8, 168.4, 146.2, 145.5, 141.5, 136.4,
133.3, 132.3, 132.2, 131.8, 129.3, 123.4, 82.1, 81.1, 77.1, 76.2,
73.9, 73.1, 70.4, 70.0, 61.0, 58.7, 47.3, 43.6, 41.0, 40.8, 36.2, 34.9,
30.1, 26.1, 24.8, 18.3, 17.9, 17.4, 16.3, 14.0, 11.9, 11.1, 10.3, 7.5,
7.4, 7.3, 7.2, 7.1, 6.6, 5.9, 5.8, 5.6, 5.4, -4.0, -4.5; HRMS (ESI)
m/z 1371.9600 [(M + Li)+ calcd for C73H144O11Si6Li, 1371.9484].
Apoptolidinone A. To solution of 6.4 mg (4.7 µMol) macro-
lactone 38 i n2m Lo fT H Fa t-10 °C was added HF-Py (0.1 mL)
dropwise. After 1 h the temperature was raised to 0 °C and after
an additional 12 h to 10 °C. After 36 h the reaction mixture was
diluted with Et2O, washed with water, and concentrated in vacuo,
leaving ca. 2 mL of Et2O. (It was noticed that drying over MgSO4
signiﬁcantly decreased the amount of product in the solution.) The
residue was puriﬁed by ﬂash chromatography (CH2Cl2/MeOH, 15:
1) to afford 3 mg (94%) of apoptolidinone A as a white solid: [R]25
D
+68°(c 0.15, CHCl3); IR (neat) 3395, 2925, 1664, 1596, 1390, 1258,
1095, 1023, 968, 754, 710 cm-1; 1H NMR (500 MHz, CD3OD) δ
7.37 (s, 1H), 6.19 (s, 1H), 6.10 (d, J ) 16.0 Hz, 1H), 5.64 (dd, J
) 9.0, 7.0 Hz, 1H), 5.33 (dd, J ) 15.5, 8.5 Hz, 1H), 5.32-5.29
(m, 1H), 5.22 (d, J ) 10.5 Hz, 1H), 4.09 (ddd, J ) 9.0, 3.5, 2.5
Hz, 1H), 3.77 (app t, J ) 9.5 Hz, 1H), 3.74 (dd, J ) 11.0, 5.0 Hz,
1H), 3.53-3.58 (m, 2H), 3.45-3.42 (m, 1H), 3.36 (s, 3H), 3.30
(s, 3H), 3.23-3.15 (m, 2H), 2.73 (dd, J ) 10.0, 4.5 Hz, 1H),
2.52-2.41 (m, 2H), 2.19 (s, 3H), 2.18-2.13 (m, 1H), 2.11 (s, 3H),
2.09-2.02 (m, 2H), 1.92 (d, J ) 1.0 Hz, 3H), 1.78-1.72 (m, 2H),
1.67 (s, 3H), 1.60-1.51 (m, 2H), 1.44-1.37 (m, 1H), 1.32-1.26
(m, 1H), 1.13 (d, J ) 6.5 Hz, 3H), 1.02 (d, J ) 6.5 Hz, 3H), 0.88
(d, J ) 7.0 Hz, 3H); 13C NMR (100 MHz, CD3OD) δ 172.7, 149.1,
147.3, 143.7, 137.7, 134.9, 133.1, 133.0, 132.6, 129.6, 123.8, 101.3,
83.8, 80.6, 78.6, 75.5, 74.6, 73.7, 72.3, 69.2, 68.1, 61.4, 59.4, 41.0,
40.8, 38.6, 38.4, 36.6, 36.4, 24.5, 17.8, 17.8, 16.4, 14.0, 12.2, 12.1,
5.3; HRMS (ESI) m/z 687.4298 [(M + Li)+ calculated for
C37H60LiO11, 687.4296].
Apoptolidinone D. To solution of 19.9 mg (14.7 µMol)
macrolactone 42 i n4m Lo fT H Fa t-10 °C was added HF-Py
(0.2 mL) dropwise. After 1 h the temperature was raised to 0 °C
and after an additional 12 h to 10 °C. After 36 h the reaction mixture
was diluted with Et2O, washed with water, and concentrated in
vacuo leaving ca. 4 mL of Et2O. (It was noticed that drying over
MgSO4 signiﬁcantly decreased the amount of product in the
solution.) The residue was puriﬁed by ﬂash chromatography
(CH2Cl2/MeOH, 15:1) to afford 8.5 mg (87%) of apoptolidinone
D as a off-white solid: [R]25
D +67.5°; IR (neat) 3382, 2927, 2362,
1666, 1599, 1457, 1390, 1255, 1100, 1024, 965, 754 cm-1; 1H NMR
(600 MHz, CD3OD) δ 7.39 (s, 1H), 6.27-6.22 (m, 2H), 5.99 (d, J
) 15.6 Hz, 1H), 5.57 (t, J ) 8.1 Hz, 1H), 5.48-5.44 (m, 1H),
5.32-5.28 (m, 2H), 4.08 (dt, J ) 8.4, 2.4 Hz, 1H), 3.78-3.73 (m,
2H), 3.55-3.50 (m, 1H), 3.53 (d, J ) 1.2 Hz, 1H), 3.42-3.35 (m,
2H), 3.37 (s, 3H), 3.26 (s, 3H), 3-18-3.12 (m, 2H), 2.66 (dd, J )
9.6, 5.4 Hz, 1H), 2.49-2.42 (m, 1H), 2.30-2.23 (m, 1H),
2.17-1-95 (m, 5H), 2.13 (s, 3H), 2.08 (s, 3H), 1.79-1.72 (m,
2H), 1.72-1.53 (m, 3H), 1.64 (s, 3H), 1.43-1.22 (m, 4H), 1.18
(d, J ) 6.6 Hz, 3H), 1.02 (d, J ) 6.6 Hz, 3H), 0.87 (d, J ) 6.6 Hz,
3H); 13C NMR (150 MHz, CD3OD) δ 172.6, 147.5, 146.0, 143.0,
137.4, 135.0, 133.5, 132.2, 130.9, 126.6, 124.2, 101.3, 84.0, 80.0,
78.5, 75.4, 74.9, 73.8, 72.5, 69.2, 68.1, 61.4, 59.4, 46.7, 40.9, 38.5,
38.3, 36.3, 36.1, 24.8, 18.6, 15.6, 13.9, 12.2, 12.1, 5.3; HRMS
(MALDI) m/z 689.3881 [(M + Na)+ calcd for C36H58NaO11,
689.3877].
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